Asia-Pacific
Envafolimab, the First Subcutaneously Administered PD-L1 Antibody for HBV Enters Phase IIb Study
2020-12-07
Taiwan Kicks off 2020 Healthcare Expo, Targeting Strategies to Boost Digital Transformation in Biopharma Industry
2020-12-03
China’s Regulatory Body Accepts Application for First Selective Internal Radiation Therapy for HCC
2020-11-29
Russian Vaccine Makers Nudge AstraZeneca to Combine COVID-19 Vaccine, AZD1222 with Sputnik V
2020-11-28
Over 1000 Pharma & Biotech players across Asia and beyond to gather virtually in December!
2020-11-27
D3 Bio Launches with $200 Million to Advance Precision Medicine in Oncology and Immunology Space
2020-11-22
LATEST
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09
Infinitopes’ Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
2024-05-09
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08